Abstract
Extracts of Cimicifuga racemosa (L.) Nutt. (syn.: Actaea racemosa L.) (CR) inhibit the proliferation of the human prostate cancer cell line LNCaP. Recently, the phenylpropanoid ester 3,4-dihydroxyphenacyl caffeate (petasiphenone, 1) was isolated from CR. This substance is a structural homologue to petasiphenol ([3-(3,4-dihydroxyphenyl)-2-oxopropyl caffeate]), a compound produced by Petasites japonicus Sieb. & Zucc. which inhibits the growth of various human leukemia cell lines. Because of the structural similarity, we examined whether 1 affects the proliferation of LNCaP cells and the secretion of prostate-specific antigen (PSA). Under basal conditions as well as under co-incubation with 10 nM estradiol [E2 or 1 nM dihydrotestosterone (DHT)], 1 dose-dependently inhibited proliferation of LNCaP cells while PSA release per cell was not altered. We report for the first time that a defined compound isolated from CR inhibits the growth of the human prostate cancer cells LNCaP.
References
-
1
Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R.
Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.
Anticancer Res.
2005;
25
139-47
-
2
Jarry H, Thelen P, Christoffel V, Spengler B, Wuttke W.
Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP.
Phytomedicine.
2005;
12
178-82
-
3
Stromeier S, Petereit F, Nahrstedt A.
Phenolic esters from the rhizomes of Cimicifuga racemosa do not cause proliferation effects in MCF-7 cells.
Planta Med.
2005;
71
495-500
-
4
Mizushina Y, Hirota M, Murakami C, Ishidoh T, Kamisuki S, Shimazaki N. et al .
Some anti-chronic inflammatory compounds are DNA polymerase lambda-specific inhibitors.
Biochem Pharmacol.
2003;
66
1935-44
-
5
Matsubara K, Mori M, Mizushina Y.
Petasiphenol which inhibits DNA polymerase lambda activity is an inhibitor of in vitro angiogenesis.
Oncol Rep.
2004;
11
447-51
-
6
Mizushina Y, Kamisuki S, Kasai N, Ishidoh T, Shimazaki N, Takemura M. et al .
Petasiphenol: a DNA polymerase lambda inhibitor.
Biochemistry.
2002;
41
14 463-71
-
7
Culig Z, Klocker H, Bartsch G, Hobisch A.
Androgen receptors in prostate cancer.
Endocr Relat Cancer.
2002;
9
155-70
-
8
Arnold J T, Le H, McFann K K, Blackman M R.
Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Am J Physiol Endocrinol Metab.
2005;
288
E573-84
-
9
Jana N R, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C, Sone H.
Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells.
Biochem Biophys Res Commun.
1999;
256
462-8
Prof. Dr. Hubertus Jarry
Division of Clinical and Experimental Endocrinology
Department of Obstetrics and Gynaecology
University of Göttingen
Robert Koch-Strasse 40
37075 Göttingen
Germany
Telefon: +49-551-396-522
Fax: +49-551-396-518
eMail: hubjarry@med.uni-goettingen.de